Marketing-authorisation holder Β· Canada
Immunomedics, Inc.
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CEA-SCAN1.25 mg / vial Β· Powder For Solution | Arcitumomab | Canada | Cancelled | |
| LEUKOSCAN0.31 mg / vial Β· Powder For Solution | Sulesomab | Canada | Cancelled |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 2 | 0 | 2 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.



